Changes in natural killer cell activity by external radiotherapy and/or brachytherapy

Oncology Reports

Volumn 9, Issue 2, 2002, Pages 359-363

  Yamazaki, Hideya ^a,b   Yoshioka, Yasuo ^b   Inoue, Takehiro ^b   Tanaka, Eiichi ^b   Nishikubo, Miki ^a   Sato, Tadayuki ^a   Ishida, Takeshi ^a   Nakamura, Hironobu ^b   Inoue, Toshihiko ^b  

^a TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brachytherapy; Natural killer cell activity; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; NEOPLASM; RADIATION EXPOSURE;

ADULT; AGED; BRACHYTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEOPLASMS;

EID: 0036515610     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.2.359     Document Type: Article

References (21)

1. Mandeville R, Salwa Sidrac-Ghali S, Ajdukovic I, Vidal D and Ayoub J: Early inhibition of natural and interferon-activated killers in endometrial cancer patients treated with local radiotherapy. Cancer Detect Prev 10: 129-139, 1987.
2. Sekiguchi I, Suzuki M, Izumi A, Aida I and Tamada T: The study on the immunological effect of sizofiran combined with radiotherapy in patients with uterine cervical cancer. J Jpn Cancer Ther 25: 2689-2664, 1990.
3. Watanabe Y, Shimizu J, Hashizume Y, et al: Immune reactivity in bronchogenic carcinoma and its relation to 5-year survival rate. J Surg Oncol 45: 103-109, 1990. (Pubitemid 20353695)
4. McGinnes K, Florence J and Penny R: The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients. J Clin Immunol 7: 210-217, 1987. (Pubitemid 17095447)
5. Pinel MIS, Esteves EB and Rumjanek VM: Increased natural killer cell activity in uterine cervix cancer patients undergoing radiation therapy. Nat Immun 14: 216-224, 1995. (Pubitemid 26146449)
6. Macklis RM, Mauch PM, Burakoff SJ and Smith BR: Lymphoid irradiation results in long-term increase in natural killer cells in patients treated for Hodgkin's disease. Cancer 69: 778-783, 1992.
7. Onsud M and Thorsby E: Long term changes in natural killer activity after external pelvic radiotherapy. Int J Radiat Oncol Biol Phys 7: 609-614, 1981.
8. Pross HF and Lotzova E: Role of natural killer cells in cancer: Nat Immun 12: 279-292, 1993. (Pubitemid 23297445)
9. Balaram P, Radmanabhan TK, Abraham T, Hareendran NK and Nair MK: Immune function in malignant cervical neoplasia: a multiparameter analysis. Gynecol Oncol 31: 409-423, 1988.
10. Vaquer S, Jorda J, Lopez de la Osa E, Alvarez de los Heros J, Lopez-Garcia N and Alvarez de mon M: Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol 35: 90-92, 1990.
11. El-Baradie M, Inoue T, Inoue T, et al: HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol 173: 155-162, 1997.
12. Yamazaki H, Inoue T, Ikeda H, et al: High-dose-rate remote afterloading intestinal radio-therapy employing the template technique for recurrent cancer in the pelvic area. Strahlenther Onkol 169:481-485, 1993. (Pubitemid 23253471)
13. Yamazaki H, Inoue T, Yoshida K, et al: Influence of age on the results of brachytherapy for tongue cancer. Int J Radiat Oncol Biol Phys 49: 931-693, 2001.
14. Yoshioka Y, Nose T, Yoshida K, et al: High-dose-rate interstitial brachytherapy as a mono-therapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48: 675-681, 2000.
15. Louagie H, van Eijkeren M, Philippe J, Thierens H and De Ridder L: Changes in peripheral blood lymphocyte subsets in patients undergoing radiotherapy. Int J Radiat Biol 75: 767-771, 1999. (Pubitemid 29298109)
16. Yamaue H, Tanimura H, Aoki Y, et al: Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer. J Surg Oncol 49: 10-15, 1992.
17. Blomgren H, Baral E, Esmyr F, Strender LE, Patrini B and Wasserman J: Natural killer activity in peripheral lymphocyte population following local radiation therapy. Acta Radiol Oncol 19: 139-143, 1980. (Pubitemid 10056733)
18. Petrini B, Wasserman J and Blomgren H: T-cell subsets in patients treated with pelvic irradiation for cancer. J Clin Lab Immunol 17: 147-148, 1985. (Pubitemid 16247445)
19. Hersey P, Edwards A, Milton GW and McGarthy WH: No evidence for association between natural killer cell activity and prognosis in melanoma patients. Nat Immun Cell Growth Regul 3: 1-6, 1984.
20. Shantz SP and Ordonez NG: Quantification of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat Immun Cell Growth Regul 10: 278-288, 1993.
21. Tartter PA, Steinberg B, Barron DM and Martinelli G: The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 122: 1264-1268, 1987. (Pubitemid 18021280)